News Focus
News Focus
icon url

gershfinance

07/27/07 11:43 AM

#7735 RE: enemem #7734



"tightening credit may also decrease the likelihood of a COR buy-out."

Given all the cash Big Pharma is sitting on, I doubt that. Cortex isn't an LBO/PE buyout candidate.